
Opinion|Videos|February 26, 2024
LIGHTHOUSE Trial and The Role of 18F-rhPSMA-7.3 for Staging of Prostate Cancer
Dr. Chapin and fellow expert oncologists discuss the latest data from the LIGHTHOUSE trial, evaluating 18F-rhPSMA-7.3 for staging patients with prostate cancer.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study launches of MRI plus PSMA-PET imaging for prostate cancer detection
2
Initial ARID results published in World Journal of Urology as pivotal trial progresses
3
New Data Influencing your Treatment Decisions in mCSPC
4
CREST and POTOMAC: Redefining immunotherapy’s role in NMIBC
5




















